Drug Target Review
DECEMBER 14, 2023
Throughout the course of our lives, natural and environmental factors can break DNA. Breaks in both DNA strands are a particularly dangerous threat to genome stability. At a DNA double-strand break (DSB), potentially lost sequence information cannot be recovered from the same DNA molecule.
Codon
AUGUST 27, 2024
Allison Berke makes the case for real-time DNA sequencing and AI tools to detect pathogens before they spread widely. Reading DNA The first step in detecting a novel pathogen is recognizing it as an anomaly amidst a noisy background of other material. After copying the DNA to form a big pool, each piece is sequenced.
PLOS: DNA Science
JULY 27, 2023
Genomics applies to all species, revealing evolution in action, because we all use the same genetic code – that is, the correspondence between DNA sequences and the amino acid sequences of proteins. Cats and Bird Flu Comparing DNA sequences is a little like linguistic research that connects languages.
PLOS: DNA Science
JUNE 13, 2024
Experiments at the Wuhan facility were done at the lowest two of the four standard biosafety levels, which were established at the dawn of recombinant DNA research in the 1970s. The Likely Predecessor of SARS-CoV-2 – From my Past Blog Posts I wrote 100+ DNA Science blog posts during the pandemic about the virus.
BMG Labtech
OCTOBER 4, 2023
These numbers reflect impressive developments in DNA sequencing technologies but in most cases represent the immediate costs of consumables on the sequencing instrument. 2 DNA sequencing is also reliant on sample processing and DNA library preparation before sequencing as well as bioinformatics and data analysis after sequencing.
Drug Target Review
MAY 24, 2024
2 AlphaFold 3 has been built to model DNA, RNA and smaller molecules (ligands). Google DeepMind’s new AI can model DNA, RNA, and ‘all life’s molecules’. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. Alphafold 3.0: the AI protein predictor gets an upgrade.
PLOS: DNA Science
OCTOBER 17, 2024
The original approved was in 2003 to treat a type of Gaucher disease. The post New Drug Miplyffa Approved for Rare Niemann-Pick Disease Type 3 appeared first on DNA Science. The new drug is taken with miglustat , which FDA approved for use in NPD3 in 2009. But like many new treatments for a rare disease, the price is high.
Expert insights. Personalized for you.
59 
Let's personalize your content